Leonidas C Platanias

  • 21438 Citations
1985 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

chronic leukemias, multiple myeloma, non-hodgkin's lymphoma

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

1984Residency, Hellenic Anticancer Institute
1989Residency, SUNY/State University of New York Downstate Medical Center
1992Fellowship, University of Chicago Hospitals

Education/Academic qualification

PhD, University of Patras Medical School

… → 1989

MD, University of Patras Medical School

… → 1983

Research interests

  • Leukemia
  • Lymphomas
  • Multiple Myeloma

Fingerprint Dive into the research topics where Leonidas C Platanias is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Interferons Medicine & Life Sciences
Interferon Type I Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Phosphorylation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Sirolimus Medicine & Life Sciences
Chemical activation Chemical Compounds
p38 Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2024

Cyclin-Dependent Kinase 9
Protein Transport
Acute Myeloid Leukemia
Protein Biosynthesis
scientific journal
pilot project

Research Output 1985 2019

2 Citations (Scopus)

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia

Beauchamp, E. M., Abedin, S. M., Radecki, S. G., Fischietti, M., Arslan, A. DI., Blyth, G. T., Yang, A., Lantz, C., Nelson, A., Goo, Y. A., Akpan, I., Eklund, E. A., Frankfurt, O., Fish, E. N., Thomas, P. M., Altman, J. K. & Platanias, L. C., Jan 1 2019, In : Blood. 133, 11, p. 1171-1185 15 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinase 9
Acute Myeloid Leukemia
Chemical activation

Impact of myosteatosis in survivors of childhood acute lymphoblastic leukemia

Rossoff, J. & Platanias, L. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints

Nora Vaz Saleiro, D. & Platanias, L. C., Jan 1 2019, (Accepted/In press) In : Seminars in Immunology. 101299.

Research output: Contribution to journalReview article

Antineoplastic Agents
Gene Expression

Natural killer cell activity and survival after azacitidine treatment in high-risk MDS

Abedin, S. M. & Platanias, L. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

Natural Killer Cells
Cell Survival

Policy challenges and opportunities to address changing paradigms in cancer care delivery

Winckworth-Prejsnar, K., McCanney, J., Schatz, A. A., Smedley, W., Platanias, L. C., Benitez, C. M., Newcomer, L. N., Lyn Fitzgerald, C. & Carlson, R. W., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 5, p. 424-431 8 p.

Research output: Contribution to journalArticle

Open Access
Quality of Health Care
Delivery of Health Care
Investigational Therapies
Group Processes